Dilafor
Pre-clinical30-50 percent of term pregnant women experience planned start of labor wich carries a high risk of complications for mothers and infants.
Founded
2008
Focus
Biologics
About
30-50 percent of term pregnant women experience planned start of labor wich carries a high risk of complications for mothers and infants.
Funding History
2Total raised: $25M
Series B$15MIndustrifondenMar 15, 2015
Series A$10MIndustrifondenMay 15, 2012
Company Info
TypePrivate
Founded2008
LocationGothenburg, Sweden
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile